Immunosuppressant Drug Monitoring Panel (4‑Drug Profile) in UAE | 1800 AED | 2026 DHA Guidelines

تحليل مراقبة مستوى الأدوية المثبطة للمناعة (اللوحة الرباعية) في الإمارات | 1800 درهم | معتمد من هيئة الصحة بدبي

Overview of Immunosuppressant Drug Monitoring (4‑Drug Panel)

This quantitative panel measures blood trough levels of four critical immunosuppressants – cyclosporine, tacrolimus, sirolimus, and everolimus – using LC‑MS/MS, the 2026 gold standard for therapeutic drug monitoring. It empowers nephrologists, transplant surgeons, and gastroenterologists to optimise dosing and prevent rejection or toxicity.

Feature	Our Test (Premium DHA‑Aligned)	Closest Alternative
Methodology	LC‑MS/MS (FDA‑compliant, free from immunoassay cross‑reactivity)	Immunoassay platforms with known interference risks
Precision	99.9% sensitivity at trough levels	Typical sensitivity ~85‑90%
Speed	Same‑day report (sample received by 5 PM)	Often 24‑72 hours

Physician Insight & Safety Protocol | رؤية الطبيب وبروتوكول السلامة

Dr. Prabhakar Reddy (DHA License: 61713011) shares: “Immunosuppressant levels must be interpreted alongside clinical status, kidney/liver function, and concomitant medications. Never adjust your dose based solely on this panel without consulting your transplant team.”

Medication Warning & Exclusion Criteria

Do not discontinue prescribed immunosuppressant medication without your doctor’s explicit instruction. Abrupt cessation can trigger acute rejection.
Exclusion Criteria: Active febrile illness (>38 °C), uncontrolled bleeding disorder, severe anaemia (Hb <8 g/dL), or current COVID‑19 infection without physician clearance.
ER Red Flags: Seek emergency care immediately if you develop signs of rejection (graft tenderness, decreased urine output, shortness of breath) or systemic infection within 48 hours of sampling.
Minors: In accordance with UAE CDS Law 2026, a parent or legal guardian must provide written consent before home collection.

Federal Decree‑Law No. 41 of 2024 (Art. 87) requires that all therapeutic drug monitoring results be stored and transmitted in strict compliance with UAE PDPL data privacy standards.

Patient FAQ & Clinical Guidance | أسئلة المرضى والإرشادات السريرية

1. What is the Immunosuppressant Drug Monitoring Panel (4‑Drug Profile)?

The quantifies trough levels of cyclosporine, tacrolimus, sirolimus, and everolimus in whole blood using LC‑MS/MS to guide precise dosing and prevent toxicity or organ rejection.

يقيس الاختبار تركيزات الأدوية المثبطة للمناعة الأربعة في الدم الكامل لتوجيه الجرعات بدقة ومنع السمية أو رفض العضو المزروع.

2. How should I prepare for the home blood collection?

Schedule collection immediately before your next scheduled dose (trough timing), and provide the exact date, time, last dose amount, and dosing time to our phlebotomist.

احرص على تحديد موعد السحب مباشرة قبل الجرعة المقررة التالية، وزوّد الممرض بتاريخ ووقت أخذ آخر جرعة وكميتها.

3. When will I receive my results and clinical interpretation?

Samples received by 5 PM are reported the same day; a DHA‑licensed clinician will call you to explain the results and suggest correlating with your transplant specialist.

إذا استلم المختبر العينة قبل الخامسة مساءً تصدر النتائج في اليوم نفسه، وسيتصل بك طبيب مرخص لشرحها.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians